Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Chesnara ( (GB:CSN) ) is now available.
Chesnara reported strong financial performance in its 2025 interim results, with a 26% increase in cash generation to £37m and a 3% rise in the interim dividend. The company announced a transformational acquisition of HSBC Life (UK), expected to significantly boost cash generation and support long-term growth. Chesnara’s strategic progress includes a successful rights issue and admission to the FTSE 250 Index, positioning the company for further expansion and shareholder value enhancement.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £290.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Spark’s Take on GB:CSN Stock
According to Spark, TipRanks’ AI Analyst, GB:CSN is a Outperform.
Chesnara’s overall score is driven by positive corporate events and a solid financial recovery, despite a high P/E ratio suggesting potential overvaluation. Technical indicators support a stable trend, enhancing the stock’s appeal alongside a robust dividend yield.
To see Spark’s full report on GB:CSN stock, click here.
More about Chesnara
Chesnara is a European life and pensions consolidator listed on the London Stock Exchange. It administers nearly one million policies and operates as Countrywide Assured in the UK, as Scildon in the Netherlands, and as Movestic in Sweden. Chesnara focuses on efficiently administering life and savings policies, writing profitable new business in the UK, Sweden, and the Netherlands, and undertaking value-adding acquisitions.
Average Trading Volume: 655,836
Technical Sentiment Signal: Buy
Current Market Cap: £664.3M
For a thorough assessment of CSN stock, go to TipRanks’ Stock Analysis page.